PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Staubli 11 March 2024, 13:59
Catalent: Mon 28 October 2024, 13:21
Novo Nordisk 20 March 2024, 11:21
Biosynth: Fri 4 October 2024, 10:42
Fifteen Years of Cardiac Safety: History, State-of-the- Science Research, and Glimpses into the Future
V5 I1 Special Feature

Fifteen Years of Cardiac Safety: History, State-of-the- Science Research, and Glimpses into the Future

The field of cardiac safety employs clinical, statistical, and regulatory sciences during the preclinical and clinical development program of a noncardiac drug to pr...
Continue Reading →
Counterfeit medicines: a real danger to patients
V5 I1 Packaging

Counterfeit medicines: a real danger to patients

Counterfeit medicine has been a subject of much concern for as long as the health and pharmaceutical sector has been established. Counterfeit drugs are a social prob...
Continue Reading →
Collaborative Development: Finding Solutions for the Packaging Challenges of Modern Injectable Biologics
V5 I1 Packaging

Collaborative Development: Finding Solutions for the Packaging Challenges of Modern Injectable Biologics

For the past 20 years, biotechnology medicines have aided those suffering from chronic conditions, including cancer, diabetes, and auto-immune diseases such as multi...
Continue Reading →
Pure and Safe
V5 I1 Manufacturing

Pure and Safe

Sterile services departments must ensure the consistent supply of sterilised tools and equipment throughout the hospital, and failure or delay can be distressing or ...
Continue Reading →
Hands-on Lean Plus
V5 I1 Manufacturing

Hands-on Lean Plus

Socio-economic pressure as well as increasingly strong competition have clearly made the entire healthcare industry focus a lot of attention on reducing costs. Not s...
Continue Reading →
The Insulin Peptide Family
V5 I1 Manufacturing

The Insulin Peptide Family

Insulin is only one member of a family of peptide hormones and growth factors that comprises 10 members in humans: insulin, insulin-like growth factors I and II and ...
Continue Reading →
Optimised Connectivity is Fundamental to Integrity & Safety of Hygienic Processing
V5 I1 Labs & Logistics

Optimised Connectivity is Fundamental to Integrity & Safety of Hygienic Processing

Every product for consumption, ingestion, injection, or cosmetic use must be safe for use and be in perfect condition when used. Micro- organisms, toxic substances a...
Continue Reading →
Patient Recruitment: The Most Recognised Silent Driver of Clinical Development Costs.
V5 I1 Clinical / Medical Research

Patient Recruitment: The Most Recognised Silent Driver of Clinical Development Costs.

Patient recruitment challenges the drug development process for a number of reasons. Elio Evangelista at Cutting Edge Information discusses why the increased demand ...
Continue Reading →
Personalised Medicine Inventions – Is Patent Protection Possible?
V5 I1 Clinical / Medical Research

Personalised Medicine Inventions – Is Patent Protection Possible?

Personalised Medicine Inventions – Is Patent Protection Possible? A recent decision from the US Supreme Court now questions whether patent protection for personalis...
Continue Reading →
Biobank Management Systems
V5 I1 Clinical / Medical Research

Biobank Management Systems

Biobanks are increasingly playing an important role in biotechnology, pharmaceutical and medical research. John Boother at Autoscribe Ltd looks into why the ability ...
Continue Reading →
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Stoelzle Skyscraper: 27th November 2024
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35
Novonordisk: Wed 17 July 2024, 13:49